Real Clinical Data Access

Real-World Clinical Data for AI Models

Why synthetic data is not enough

Synthetic clinical data has value for prototyping and testing. It does not have value for training production clinical AI models. The reasons are fundamental:

What "real clinical data" means in practice

Real clinical data means data generated during actual care delivery:

How to access it without moving it

Rapha Protocol provides the technical bridge: researchers specify the dataset profile, modality, cohort criteria, and model architecture. The protocol routes the workload into the hospital environment where the data lives. Training executes locally. Researchers receive trained weights, metrics, and proof receipts — not raw data.

This is not a data marketplace. It is not a data broker. It is compute-to-data infrastructure. The researcher never downloads, stores, or processes raw clinical records. The hospital never exports, transfers, or sells patient data. The transaction is access to compute on data — not access to data itself.

Current early-access modalities

Important: Rapha Protocol is private-alpha. Modality availability depends on configured hospital nodes. No claim is made that production hospital PHI has been processed through the public proof surface. The mainnet proof receipt demonstrates cryptographic infrastructure, not clinical data processing volume.